SILVERARC CAPITAL MANAGEMENT, LLC

Position in SRRK — Scholar Rock Holding Corp

CIK 1816307 BOSTON, MA

Position in SRRK

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$16,695,375

+$7,984,195 QoQ

Shares Held

339,613

+45.2% QoQ

Ownership

0.283%

of shares outstanding

% of Portfolio

1.97%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SILVERARC CAPITAL MANAGEMENT, LLC holds $782,503,784 across 55 Biotechnology names. SRRK ranks #18 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KALV	KalVista Pharmaceuticals, Inc.	2,876,407	$57,902,072
2	DNTH	Dianthus Therapeutics, Inc. /DE/	654,746	$54,946,284
3	COGT	Cogent Biosciences, Inc.	1,314,189	$50,583,134
4	CELC	Celcuity Inc.	357,903	$40,851,048
5	IMNM	Immunome Inc.	1,850,278	$40,465,579
6	KOD	Kodiak Sciences Inc.	991,930	$37,812,371
7	NUVL	Nuvalent, Inc.	354,914	$36,360,939
8	ABVX	Abivax S.A.	302,530	$33,686,715

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$16,695,375	339,613	+45.2%	Shares	Sole	2026-05-14
2025-09-30	$8,711,180	233,920	-31.4%	Shares	Sole	2025-11-12
2025-06-30	$12,078,574	341,010	+86.1%	Shares	Sole	2025-08-14
2024-12-31	$7,919,762	183,243	-8.1%	Shares	Sole	2025-02-14
2024-03-31	$3,541,610	199,415	-26.1%	Shares	Sole	2024-05-15
2023-12-31	$5,076,000	270,000	+2680.4%	Shares	Sole	2024-02-14
2023-09-30	$68,948	9,711	-73.2%	Shares	Sole	2023-11-13
2021-03-31	$1,834,955	36,221	+44.9%	Shares	Sole	2021-05-18
2020-12-31	$1,213,250	25,000	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.